ライフサイエンスコーパス: antibiotic prophylaxis

1 69%) studies reported use of any intrapartum antibiotic prophylaxis.

2 coureteral reflux management with surgery or antibiotic prophylaxis.

3 pore exposure requires a prolonged course of antibiotic prophylaxis.

4 ed until 14 days after the administration of antibiotic prophylaxis.

5 by minimizing the delay until initiation of antibiotic prophylaxis.

6 ux nephropathy can be reduced effectively by antibiotic prophylaxis.

7 alational anthrax is the optimum duration of antibiotic prophylaxis.

8 omen were also scheduled to receive standard antibiotic prophylaxis.

9 There is substantial underuse and overuse of antibiotic prophylaxis.

10 oach) to identify candidates for intrapartum antibiotic prophylaxis.

11 techniques, diagnosis in young infants, and antibiotic prophylaxis.

12 of delayed graft function, and perioperative antibiotic prophylaxis.

13 -risk subset of persons who may benefit from antibiotic prophylaxis.

14 the root words endocarditis, bacteremia, and antibiotic prophylaxis.

15 ggested to balance the risks and benefits of antibiotic prophylaxis.

16 us, IE cannot be prevented by circumstantial antibiotic prophylaxis.

17 in the incidence of SSIs was amikacin use as antibiotic prophylaxis.

18 ive vaccination, education, and occasionally antibiotic prophylaxis.

19 high compliance with standard perioperative antibiotic prophylaxis.

20 an effective option for surgeons electing IC antibiotic prophylaxis.

21 n were similar with either <24 h or <48 h of antibiotic prophylaxis.

22 om cephalosporins to gentamicin for surgical antibiotic prophylaxis.

23 e index case highlights a potential role for antibiotic prophylaxis.

24 transplantation, with limited data to guide antibiotic prophylaxis.

25 idated questionnaire evaluating adherence to antibiotic prophylaxis.

26 alvulopathy and can be entirely prevented by antibiotic prophylaxis.

27 hesiologists score, and choice and timing of antibiotic prophylaxis.

28 nt scenarios of reduction in the efficacy of antibiotic prophylaxis (10%, 30%, 70%, and 100% reductio

29 Despite evidence supporting short antibiotic prophylaxis (ABP), it is still common practic

30 tudies are needed to answer the questions on antibiotic prophylaxis across the spectrum of UTI in dif

31 This study suggests that antibiotic prophylaxis after endoscopic hemostasis for a

32 ought to determine whether a short course of antibiotic prophylaxis after exposure could protect non-

33 have raised serious doubts about the role of antibiotic prophylaxis after UTI by demonstrating the pr

34 ry, there are still no definitive studies on antibiotic prophylaxis against endophthalmitis after cat

35 Although antibiotic prophylaxis against infective endocarditis is

36 red children with SCD may receive inadequate antibiotic prophylaxis against pneumococcal infections,

37 (5) A poor choice of antibiotic prophylaxis agent occurred in 8% of patients

38 hanced the protection afforded by 14 days of antibiotic prophylaxis alone and completely protected an

39 -would have the greatest impact on uptake of antibiotic prophylaxis among patients with RHD in Uganda

40 cal CNS prophylaxis and supportive care with antibiotic prophylaxis and granulocyte colony-stimulatin

41 Antibiotic prophylaxis and growth factor support were re

42 the isolates were resistant to the systemic antibiotic prophylaxis and in none of six cases with sus

43 Therapeutic strategies such as antibiotic prophylaxis and microbiological diagnosis are

44 ng stone surgery can be catastrophic despite antibiotic prophylaxis and sterile pre-operative urine.

45 to investigate changes in the prescribing of antibiotic prophylaxis and the incidence of infective en

46 eting-risks model to address the duration of antibiotic prophylaxis and the incubation period that ac

47 isk, they receive pneumococcal vaccines, and antibiotic prophylaxis and treatment.

48 with subsequent testing for reflux, urinary antibiotic prophylaxis, and prompt treatment of urine in

49 ions at discharge, selection and duration of antibiotic prophylaxis, and use of the internal mammary

50 lth and Care Excellence recommended stopping antibiotic prophylaxis (AP) for those at risk of infecti

51 Appropriate use of surgical antibiotic prophylaxis (AP) reduces surgical site infect

52 als in surgery suggest that some failures of antibiotic prophylaxis are related to the in vivo degrad

53 and, if they are colonized, that intrapartum antibiotic prophylaxis be administered.

54 ion of azithromycin to standard regimens for antibiotic prophylaxis before cesarean delivery may furt

55 The value of antibiotic prophylaxis before insertion of an intrauteri

56 These data support the use of antibiotic prophylaxis before percutaneous liver biopsy

57 m the cumulative attack rate up to the point antibiotic prophylaxis begins.

58 As well as antibiotic prophylaxis being a generally effective inter

59 bstantial difference in the effectiveness of antibiotic prophylaxis between "clean" and "contaminated

60 ular, gastrointestinal, and gynecology) with antibiotic prophylaxis between October 1, 2006, and Sept

61 Antibiotic prophylaxis cannot be recommended for prevent

62 ng granulocyte colony stimulating factor and antibiotic prophylaxis causes a further reduction in inf

63 SSI, and classify patients in which standard antibiotic prophylaxis could be avoided.

64 r for wound complications on which selective antibiotic prophylaxis could be based.

65 iderable morbidity would likely occur before antibiotic prophylaxis could even be initiated.

66 odds of recurrent UTI in patients receiving antibiotic prophylaxis decreased by 47% when adjusting f

67 The optimum duration of antibiotic prophylaxis depends critically on the dose of

68 Patient adherence to antibiotic prophylaxis did not alter microbial susceptib

69 The impact of antibiotic prophylaxis during cyclical out-patient chemo

70 Although intrapartum antibiotic prophylaxis during labor and delivery has dec

71 Antibiotic prophylaxis effectively prevents not only the

72 ctive endocarditis would be preventable with antibiotic prophylaxis, even with 100% effectiveness ass

73 ean delivery who were all receiving standard antibiotic prophylaxis, extended-spectrum prophylaxis wi

74 This study aimed to determine the effective antibiotic prophylaxis for (sub)normothermic preservatio

75 that exposed persons would need to remain on antibiotic prophylaxis for at least 4 months, and consid

76 we outline the data supporting perioperative antibiotic prophylaxis for clean-contaminated surgeries,

77 infective endocarditis might be prevented by antibiotic prophylaxis for dental procedures even if suc

78 apies (including combinations) and effective antibiotic prophylaxis for HIV-infected children, and a

79 Clinical evidence now also supports antibiotic prophylaxis for low-risk patients.

80 Vancomycin is often used as surgical antibiotic prophylaxis for major surgery.

81 Our findings suggest that systemic antibiotic prophylaxis for more than 2 days may be benef

82 with regard to which patients should receive antibiotic prophylaxis for prevention of IE and for what

83 nce (NICE) recommended complete cessation of antibiotic prophylaxis for prevention of infective endoc

84 This study assessed the effectiveness of antibiotic prophylaxis for reducing pneumonia in patient

85 The aim of this study was to test whether antibiotic prophylaxis for SBP is cost-effective and to

86 In matched-pair analysis, antibiotic prophylaxis for spontaneous bacterial periton

87 Prescriptions of antibiotic prophylaxis for the prevention of infective e

88 A 30% reduction in the efficacy of antibiotic prophylaxis for these procedures would result

89 Current antibiotic prophylaxis for vascular procedures includes

90 We analysed data for the prescription of antibiotic prophylaxis from Jan 1, 2004, to March 31, 20

91 Antibiotic prophylaxis given before invasive dental proc

92 The standard antibiotic prophylaxis given to prevent the infections i

93 Despite widespread use of intrapartum antibiotic prophylaxis, group B streptococcus remains a

94 Recent changes in antibiotic prophylaxis guidelines in the USA and Europe

95 ta-lactams to glycopeptides for preoperative antibiotic prophylaxis has been controversial.

96 Antibiotic prophylaxis has been found to have multiple b

97 Neither constant nor intermittent antibiotic prophylaxis has been proven to prevent endoca

98 Antibiotic prophylaxis has been shown to decrease the in

99 Antibiotic prophylaxis has made the infectious morbidity

100 Current routine screening and antibiotic prophylaxis have fallen short of complete pre

101 blish a causal association, prescriptions of antibiotic prophylaxis have fallen substantially and the

102 such as the timing of surgery or the role of antibiotic prophylaxis have not been resolved.

103 pportive measures such as growth factors and antibiotic prophylaxis have resulted in a dramatic decre

104 d how it varies with coverage of intrapartum antibiotic prophylaxis (IAP), used to reduce the inciden

105 ontexts, despite declines due to intrapartum antibiotic prophylaxis (IAP).

106 Antibiotic prophylaxis improved survival among decompens

107 in 2007 that markedly restricted the use of antibiotic prophylaxis in certain at-risk patients under

108 This study aimed to evaluate antibiotic prophylaxis in kidney transplantation and ide

109 This review will consider the rationale for antibiotic prophylaxis in light of contemporary data reg

110 changing its previous position on the use of antibiotic prophylaxis in patients at risk of infective

111 h the use of systematic echocardiography and antibiotic prophylaxis in patients with acute Q fever an

112 The use of antibiotic prophylaxis in pediatric leukemia, myelodyspl

113 reatment of hepatorenal syndrome, a trial of antibiotic prophylaxis in preventing early variceal rebl

114 th, alternation) to estimate the efficacy of antibiotic prophylaxis in preventing infections and infe

115 IVUR) study, which will evaluate the role of antibiotic prophylaxis in preventing recurrent UTI and r

116 The role of antibiotic prophylaxis in reducing post-TRUS biopsy infe

117 ppressing cancer chemotherapies that rely on antibiotic prophylaxis in the USA.

118 individuals with resistant organisms due to antibiotic prophylaxis increases febrile neutropenia or

119 Antibiotic prophylaxis indication and administration acc

120 Scaling down antibiotic prophylaxis indications was not associated wi

121 Antibiotic prophylaxis is a cornerstone of SSI reduction

122 At very low doses, 60 days of antibiotic prophylaxis is adequate.

123 However, antibiotic prophylaxis is also associated with a clinica

124 Current guidelines recommend that antibiotic prophylaxis is considered in all patients at

125 sensible philosophy would be to assume that antibiotic prophylaxis is effective in reducing the risk

126 ux, open surgical intervention compared with antibiotic prophylaxis is no better at preventing renal

127 need an explanation when they are told that antibiotic prophylaxis is no longer recommended for them

128 nfective endocarditis (IE) guideline update, antibiotic prophylaxis is now being restricted to a smal

129 Broad-spectrum antibiotic prophylaxis is recommended for both military

130 ally reduced the number of patients for whom antibiotic prophylaxis is recommended.

131 Intrapartum antibiotic prophylaxis is the current mainstay of preven

132 f neonatal disease (with/without intrapartum antibiotic prophylaxis), maternal GBS disease, neonatal/

133 cefuroxime, suggesting that this approach to antibiotic prophylaxis may be far more effective than tr

134 lung disease, respiratory hospitalizations, antibiotic prophylaxis) measured in the first 2 years of

135 s recommended restricting the indications of antibiotic prophylaxis of IE.

136 ing, bacterial infections, and the impact of antibiotic prophylaxis on mortality at different stages

137 the effect of a single dose of preoperative antibiotic prophylaxis on the incidence of SSIs followin

138 Whereas antibiotic prophylaxis overall showed a 40% to 50% reduc

139 its of blood transfusion (p = 0.031), and no antibiotic prophylaxis (p <0.001); for bacterial infecti

140 .003), active alcoholism (p = 0.035), and no antibiotic prophylaxis (p = 0.009).

141 Antibiotic prophylaxis plays a major role in preventing

142 pectively compared the impact of a change in antibiotic prophylaxis practice from no BKV prophylaxis

143 patients received peri-operative intravenous antibiotic prophylaxis, primarily cefazolin.

144 nique in these procedures are mandatory, but antibiotic prophylaxis prior to injection of nondegradab

145 o advise patients as to whether they require antibiotic prophylaxis prior to invasive procedures.

146 these, 13 patients with valvulopathy without antibiotic prophylaxis progressed to endocarditis.

147 ciated with performance on process measures (antibiotic prophylaxis, R = -0.216 [P = .24]; appropriat

148 Antibiotic prophylaxis recommendations for the preventio

149 More data are needed to establish how antibiotic prophylaxis recommendations should be modifie

150 cin-resistant E. coli, so as to tailor their antibiotic prophylaxis, rectal swabs are screened using

151 ed trials and meta-analyses demonstrate that antibiotic prophylaxis reduces the incidence of febrile

152 Antibiotic prophylaxis reduces the incidence of fever du

153 nd longstanding controversies such as use of antibiotic prophylaxis remain unresolved.

154 sure vaccination can shorten the duration of antibiotic prophylaxis required to protect against inhal

155 ajor infection risk, but optimal duration of antibiotic prophylaxis requires further study.

156 The evidence that antibiotic prophylaxis results in adverse patient outcom

157 fidence interval (CI) for the association of antibiotic prophylaxis (route and agent) with risk of en

158 refore, the general prevailing attitude that antibiotic prophylaxis should be assumed to be ineffecti

159 Antibiotic prophylaxis should be considered in patients

160 Antibiotic prophylaxis should be offered to patients rec

161 benefit for eyes complicated by PCR, and IC antibiotic prophylaxis should be strongly considered for

162 minimizing that risk, including altering the antibiotic prophylaxis, should be investigated and imple

163 Antibiotic prophylaxis significantly decreased SSI incid

164 ct surgery, intraocular lens type, method of antibiotic prophylaxis, surgeon experience, vitreous cul

165 disease with the introduction of intrapartum antibiotic prophylaxis, this pathogen remains a leading

166 cases of IE are successfully prevented using antibiotic prophylaxis, those few cases may represent a

167 It may be possible to reduce standard antibiotic prophylaxis to a single dose in patients with

168 mately 10,000 people were offered 60 days of antibiotic prophylaxis to prevent inhalational anthrax,

169 The trend in antibiotic prophylaxis to prevent late infections in tot

170 hildren participating in a clinical trial of antibiotic prophylaxis to prevent recurrent urinary trac

171 l reviews should amend current protocols for antibiotic prophylaxis to reduce the incidence of wound

172 This study suggests that the addition of antibiotic prophylaxis to standard epidemic-control meas

173 act infection by either providing continuous antibiotic prophylaxis to sterilize the urine and thus p

174 rdship principles such as the restriction of antibiotic prophylaxis to subpopulations at a very high

175 yses of human endocarditis cases in terms of antibiotic prophylaxis usage patterns and apparent proph

176 ed time series, to investigate the effect of antibiotic prophylaxis versus no prophylaxis on the inci

177 Routine antibiotic prophylaxis was administered to all patients.

178 Weaning from breast milk and use of antibiotic prophylaxis was associated with increased lev

179 Antibiotic prophylaxis was employed in 21 patients with

180 ainage, the beneficial effect of intraductal antibiotic prophylaxis was even more evident (OR = 0.153

181 Antibiotic prophylaxis was highly effective (HR, 0.002;

182 enital heart disease (CHD) patients for whom antibiotic prophylaxis was indicated.

183 othesis and to assess the effect of systemic antibiotic prophylaxis, we obtained intraoperative cultu

184 Studies that reported use of any intrapartum antibiotic prophylaxis were associated with lower incide

185 Three strategies of topical antibiotic prophylaxis were used by the respective surge

186 rial, we assessed the efficacy and safety of antibiotic prophylaxis with ertapenem, as compared with

187 The first study to compare antibiotic prophylaxis with increased surveillance and p

188 ng randomized patients with VUR who received antibiotic prophylaxis with those who did not receive an

189 he hypotheses to be assessed were first that antibiotic prophylaxis would be an effective interventio